about
Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor.Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor.Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers.Diarylureas as allosteric modulators of the cannabinoid CB1 receptor: structure-activity relationship studies on 1-(4-chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1).Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugsSynthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs).Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodentsCurrent evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders.Use of SPME-HS-GC-MS for the analysis of herbal products containing synthetic cannabinoids.Identification of [14C]fluasterone metabolites in urine and feces collected from dogs after subcutaneous and oral administration of [14C]fluasterone.Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders.Truncated Orexin Peptides: Structure-Activity Relationship StudiesNovel, potent THC/anandamide (hybrid) analogs.The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes.The importance of hydrogen bonding and aromatic stacking to the affinity and efficacy of cannabinoid receptor CB2 antagonist, 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3-Pharmacokinetic and tissue distribution study of [14C]fluasterone in male Beagle dogs following intravenous, oral and subcutaneous dosing routes.Assessment of structural commonality between tetrahydrocannabinol and anandamide.Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols.Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats.Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.Determination of ibogaine in plasma by gas chromatography--chemical ionization mass spectrometryDetermination of l-alpha-acetylmethadol, l-alpha-noracetylmethadol and l-alpha-dinoracetylmethadol in plasma by gas chromatography-mass spectrometryQSAR analysis of Delta(8)-THC analogues: relationship of side-chain conformation to cannabinoid receptor affinity and pharmacological potencyIndenopyride derivative RTI-4587-073(l): a candidate for male contraception in stallionsAcute and chronic effects of a contraceptive compound RTI-4587-073(l) on testicular histology and endocrine function in miniature horse stallions
P50
Q30558573-45F4F0B2-E546-4714-9CC5-5EF1995A9ACBQ33693780-C55FE50F-9B42-42D7-B207-CAD1F529B9F8Q33768567-07838418-FBF3-4F96-BA7F-216BF60E847BQ34243225-6B05FBA2-7E52-4930-BF31-E925A9ED0508Q34314602-E295EC5A-D0C4-4446-980C-75468FAF6776Q34440766-C7BEE765-0AF3-4467-A081-9BF8904312CDQ34453709-E100AA70-024F-47CE-A150-10FAF7CDEB20Q36251616-EE99F48C-BE59-4545-9378-46E1F9EE9FC2Q36727502-A67628FC-2040-4C6C-9CA5-BD731FD26A19Q37195536-1AD56524-1E9F-439F-AF5D-DD45C8A49541Q37397048-3BBE3A5A-A17A-4434-887B-A02DF4E779AEQ37444808-4AD12BE0-047D-4A87-A302-CE7607849C9AQ37683433-405FA393-1147-4BC8-8876-E5382FFA5204Q40083173-6055B323-284C-40D8-B4DE-5DB8527F9010Q40987563-9CCF148D-EEE9-4723-AC5A-236C9F98EF1EQ42940086-E9953D11-57F8-4ED7-AF93-2C613BEE7262Q43259876-0AB673B8-B302-4675-AD47-1638814ED5C6Q43854025-78AEFF11-622E-4B21-A515-20C00344FAEAQ44356912-FCD43EDE-2E44-4266-A195-99DC9A1EE7C1Q48573434-F84F6CC5-93ED-46E2-B704-05A651BD4971Q54467581-9D7E5147-1B2B-4DDB-A262-00A8A773CF91Q71564464-D4D8125F-4B83-4378-A9E2-7461CA04DAB8Q72177121-7F385B53-DBA5-42A9-A9C2-F7A9B321CE1DQ73348877-E568BA62-07BC-4276-BC68-447B7D8CAA37Q87349494-E20790C2-2663-444F-BB38-ED127A4F9E71Q95561905-97F56A63-BF89-4F87-B77F-E30C93198F4C
P50
description
researcher ORCID ID = 0000-0002-0097-4804
@en
name
Brian F Thomas
@ast
Brian F Thomas
@en
Brian F Thomas
@es
Brian F Thomas
@nl
type
label
Brian F Thomas
@ast
Brian F Thomas
@en
Brian F Thomas
@es
Brian F Thomas
@nl
prefLabel
Brian F Thomas
@ast
Brian F Thomas
@en
Brian F Thomas
@es
Brian F Thomas
@nl
P1153
7401507537
P31
P496
0000-0002-0097-4804